DOCSLIB.ORG

Regenerative Medicine in China: Demands, Capacity, and Regulation Biao Cheng1,2, Shuliang Lu3 and Xiaobing Fu1,4*

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Regenerative Medicine in China: Demands, Capacity, and Regulation Biao Cheng1,2, Shuliang Lu3 and Xiaobing Fu1,4* Cheng et al. Burns & Trauma (2016) 4:24 DOI 10.1186/s41038-016-0046-8 REVIEW Open Access Regenerative medicine in China: demands, capacity, and regulation Biao Cheng1,2, Shuliang Lu3 and Xiaobing Fu1,4* Abstract Regenerative medicine (RM) is an emerging interdisciplinary field of research. Its clinical application focuses on the repair, replacement, and regeneration of cells, tissues, and organs by approaches including cell reprogramming, stem cell transplantation, tissue engineering, activating factors, and clone treatment. RM has become a hot point of research in China and other countries. China’s main and local governments have attached great importance to RM and given strong support in relevant policies and funding. About 3.5 billion RMB has been invested in this field. Since 1999, China has established about 30 RM centers and cooperates with many advanced countries in RM research and benefits from their cooperation. However, China needs to develop standards, regulations, and management practices suitable for the healthy development of RM. In this review, we focus on its great demand, capacity, and relative regulations. Keywords: Regenerative medicine, Stem cell, Tissue engineering, China Background In the past 20 years, the RM market has continued Annually, about 100 million Chinese patients will receive to grow in China and other countries such as the treatment by tissue repair and regeneration technologies USA, Europe, Japan, and Singapore. As the largest because of the sharp increase in various injuries, acci- developing country, China has impressed the world dents, and diseases of aging. However, the current para- with its findings in stem cells, tissue engineering, digm of “healing by scar tissue replacement,” regardless of active molecules, and gene therapy as well as its na- superficial tissues or visceral organs, is stagnating and is tional strategies and regulation of RM. These achieve- far away from the ultimate goal of “regenerating the im- ments may benefit China in both disease treatment paired organ.” Regenerative medicine (RM) is gradually and society development [3]. being used to restore the intrinsic repair ability with stem cell transplantation, tissue engineering, activating factors, cell reprogramming, and genetic treatments. RM holds Review sound promise of restoring organ function that is im- Strategies, guidance, funding, and industrialization of RM paired because of congenital disorders, acquired disease, in china trauma, and aging by replacing or regenerating cells, tis- National strategies sues, and even organs. RM is expected to transcend trad- The central government of China supports the develop- itional organ transplantation and replacement. Stem cell ment of RM. In the 2006 National Plan for Long- and technology and tissue engineering have an outstanding Medium-Term Scientific and Technological Development – role in RM. RM will become one of the most promising (2006 2020), stem cells and RM technologies were the im- areas of life science in the twenty-first century [1, 2]. portant fields among the five biotechnologies (http:// www.gov.cn/gzdt/2009-08/21/content_1398305.htm). Also, local governments have adopted stem cell research as one * Correspondence: [email protected] 1College of Life Sciences, Medical College of PLA, General Hospital of PLA, of the priorities of technological development and provided Beijing 100853, People’s Republic of China active support. Relevant government departments and aca- 4 Chinese Academy of Engineering (Division of Medical and Health), College demia have paid close attention to and encouraged the de- of Life Sciences, Medical College of PLA, General Hospital of PLA, 28 Fu Xian Road, Beijing 100853, People’s Republic of China velopment of RM. In the Science & Technology on Public Full list of author information is available at the end of the article Health in China: A Roadmap to 2050, issued by the © 2016 The Author(s) Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Cheng et al. Burns & Trauma (2016) 4:24 Page 2 of 7 Table 1 Management specification of stem cell transplantation and “Construction of Research Centers for Basic and techniques Forefront Scientific Research.” Academia held three Time Management specification of stem cell transplantation techniques Xiangshan Science Conferences on RM, in 2005, 2010, 2006 Unrelated Hematopoietic Stem Cell Transplantation Technique and 2015, to discuss the philosophy, scope, and major Unrelated Hematopoietic Stem Cell Transplantation Collection breakthroughs needed for the development of RM in Technique China and the key scientific issues to be addressed. In 2009 Cord Blood Stem Cell Therapy Technology (Trial) addition, the Xiangshan Science Conference organized Tissue-engineering Tissue Transplantation Therapy Technique (Trial) seminars on stem cell biology and cloning, strategies for research and development of gene therapy and biomate- rials, and tissue engineering. Chinese Academy of Sciences (CAS) [4], and the Study on the Long- and Medium-Term Development Strategy for Regulatory and scientific guidance China Engineering Science and Technology, issued by the Policies and regulations reflect that China is gradually Chinese Academy of Engineering (CAE) (http://news. strengthening the management of RM research and clinical sciencenet.cn/htmlnews/2012/12/273300-3.shtm), RM was application. Since 1999, when the Ministry of Health (MH) considered a major research field. In the Roadmap of promulgated the first Umbilical cord blood stem cell bank Translational Medicine in China issued by CAE, RM and management approach (Trial), about 30 rules and regulations biotherapy are main fields. Industrialization of RM is a part have been issued by the Ministry of Science and Technology of the “12th Five-Year Planning” and will be nurtured as a (MST), the MH, and the State Food and Drug Agency source of economic growth. (SFDA) (Table 1). The strategic science and technology projects from In 2011, the First National Stem Cell Research Guidance CAS can be divided into “Forward-Looking Strategic and Coordination Committee was established for the Priority Research Program of Science and Technology” overall design and scientific planning of stem cell research Fig. 1 National Natural Science Foundation of China investment in regenerative medicine from 2000 to 2014. a Amount of funding. b Number of funds Cheng et al. Burns & Trauma (2016) 4:24 Page 3 of 7 in China. In December 2011, the Notice on Carrying out Funding support and resources Self-inspection and Self-rectification Campaign Regarding Multiple sources are funding RM studies and transla- Stem Cell Clinical Research and Application was issued. tional application. After 1999, the MST approved the In 2013, the stem cell clinical research and application National Program on Key Basic Research Project (973 rectification lead group of the MH and SFDA formu- Program) related to tissue engineering, and the stem lated the regulations Management Specification of cell field had the largest number of “973 Program” Stem Cell Clinical Trials (Trial), Management Specifi- projects. Research into the clinical transformation and cation of Stem Cell Clinical Trial Research Base application of stem cell therapy was established in the (Trial),andStem Cell Preparation Quality Control biotechnology and medical technology field of the and Pre-clinical Research Guidelines (Trial).These “863 Program.” The National Natural Science Founda- regulations will be implemented soon and help in the tion (NNSF) funded about 200 million RMB for this development of RM in China. In 2015, China MH study, including 5627 items (Fig. 1a, b). Up to now, opens the window to allow the stem cell clinic trial about 3 billion RMB from the MST, CAS, and NNSF and stem cell research bases which will promote the has been invested in this field. Both the amount of development of stem cell research and translational funding and number of projects are increasing annu- application in China. ally. Other funding for RM from companies is about Fig. 2 Outputs of regenerative medicine research papers compared with major countries (ISI Web of Knowledge). a Stem cells. b Tissue engineering Cheng et al. Burns & Trauma (2016) 4:24 Page 4 of 7 Table 2 Main monographs on regenerative medicine published in China Time Name Author Publishing company 2008.03 Regenerative Medicine: From Basic to Clinic Fu Xiaobing, Wang Zhengguo, Shanghai Scientific and Technical Publishers Research Wu Zuze [5] 2010.05 Regenerative Medicine: Theory and Technology Pei Xuetao [6] Science Press 2012.03 Regenerative Medicine Ding Fei, Liu Wei, Gu Xiaosong [7] People’s Medical Publishing House 2013.08 Regenerative Medicine: Basic and Clinical Research Fu Xiaobing, Wang Zhengguo, People’s Medical Publishing House Wu Zuze [8] 2014.10 Tissue Engineering and Regenerative Medicine Jin yan [9] People’s Medical Publishing House 2015.03 Chinese Discipline Development Strategy Chinese Academy of Sciences [10] Science Press Regenerative
Load more

Recommended publications
  • Three Years of Stem Cell Research & Therapy
    Locke et al. Stem Cell Research & Therapy 2013, 4:46 http://stemcellres.com/content/4/3/46 EDITORIAL Three years of Stem Cell Research & Therapy Philippa Locke1*, Timothy O’Brien2 and Rocky S Tuan3 Editorial A responsible and respected publisher This year we celebrate three years of publication of Stem Since 2000, BioMed Central has been a pioneer of the Cell Research & Therapy. In this short space of time, as open access publishing model. A member of the Com- the number of journals in the stem cell and regenerative mittee on Publication Ethics (COPE), BioMed Central medicine field has grown and continues to grow dramat- regularly reviews its editorial policies and processes to ically, Stem Cell Research & Therapy has become ensure that they meet the highest standards [4]. All of established as the destination for high quality open ac- the research published in Stem Cell Research & Therapy cess research into stem cell therapeutics. is thoroughly peer-reviewed and deposited in a number of open access archives to ensure its continual availabil- ity [5]. Why Stem Cell Research & Therapy? When submitting work to a journal, authors understand- Our international, multidisciplinary Editorial Board ’ ably wish to be assured of the journal s quality. So what As well as assisting in the review of manuscripts, the Stem Cell Research & Therapy makes the leading forum Stem Cell Research & Therapy Editorial Board offers in- for translational stem cell research? valuable guidance on the journal’s commissioned con- tent and development. The Editorial Board members reflect the diversity in the field, from basic scientists to Scope, indexing, and impact clinicians, including surgeons [6].
    [Show full text]
  • Contextualizing Systems Biology Presuppositions and Implications of a New Approach in Biology Contextualizing Systems Biology
    Martin Döring Imme Petersen Anne Brüninghaus Regine Kollek Contextualizing Systems Biology Presuppositions and Implications of a New Approach in Biology Contextualizing Systems Biology Martin Döring • Imme Petersen Anne Brüninghaus • Regine Kollek Contextualizing Systems Biology Presuppositions and Implications of a New Approach in Biology Martin Döring Imme Petersen University of Hamburg University of Hamburg Hamburg , Germany Hamburg , Germany Anne Brüninghaus Regine Kollek University of Hamburg University of Hamburg Hamburg , Germany Hamburg , Germany ISBN 978-3-319-17105-0 ISBN 978-3-319-17106-7 (eBook) DOI 10.1007/978-3-319-17106-7 Library of Congress Control Number: 2015944085 Springer Cham Heidelberg New York Dordrecht London © Springer International Publishing Switzerland 2015 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifi cally the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfi lms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specifi c statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made.
    [Show full text]
  • Life & Physical Sciences
    2018 Media Kit Life & Physical Sciences Impactful Springer Nature brands, influential readership and content that drives discovery. ASTRONOMY SPRINGER NATURE .................................2 BEHAVIORAL SCIENCES BIOMEDICAL SCIENCES OUR AUDIENCE & REACH ........................3 BIOPHARMA CELLULAR BIOLOGY ADVERTISING SOLUTIONS & CHEMISTRY EARTH SCIENCES PARTNERING OPPORTUNITIES .................6 ELECTRONICS JOURNAL AUDIENCE & CALENDARS .........8 ENERGY ENGINEERING SCIENTIFIC DISCIPLINES ......................17 ENVIRONMENTAL SCIENCES GENETICS A-Z JOURNAL LIST ...............................19 IMMUNOLOGY, MICROBIOLOGY LIFE SCIENCES MATERIALS SCIENCES MEDICINE METHODS, PROTOCOLS MULTIDISCIPLINARY NEUROLOGY, NEUROSCIENCE ONCOLOGY, CANCER RESEARCH PHARMACOLOGY PHYSICS PLANT SCIENCES SPRINGER NATURE SPRINGER NATURE QUALITY CONTENT Springer Nature is a leading publisher of scientific, scholarly, professional and educational content. For more than a century, our brands have set the scientific agenda. We’ve published ground-breaking work on many fundamental achievements, including the splitting of the atom, the structure of DNA, and the discovery of the hole in the ozone layer, as well as the latest advances in stem-cell research and the results of the ENCODE project. Our dominance in the scientific publishing market comes from a company-wide philosophy to uphold the highest level of quality for our readers, authors and commercial partners. Our family of trusted scientific brands receive 131 MILLION* page views each month reaching an audience
    [Show full text]
  • Springer Nature 开放获取期刊列表 按学科分类，影响因子为2019年6月发布
    springernature.com Illustration inspired by the work of Jean-Claude Bradley Open Access Journals SPRINGER NATURE 开放获取期刊列表 按学科分类，影响因子为2019年6月发布 2019 年7月印 2 Springer Nature springernature.com 开放获取期刊列表 Multidisciplinary学科分类目录 Sciences . .4 综合性学科 Agricultural and Veterinary Sciences . 4 农业与兽医科学. Forestry, Agriculture and Food Science . .4 林学、农学&食品科学 Veterinary Sciences . .4 兽医学 Biological Sciences 5 生物科学 . Biology Multidisciplinary . .5 综合性生物科学 Biochemistry & Molecular Biology . 5 生物化学与分子生物学 Bioinformation & Computational biology . .5 生物信息学与计算生物学 Cell Biology, Developmental Biology & Physiology 5 细 胞 、发 育 、生 理 生 物 学 Ecology . .6 生态学 Evolutionary Biology . 6 进化生物学 Genetics & Heredity 6 基因与遗传学 . Microbiology . 7 微生物学 Neurosciences . .7 神经科学 Other Biological Science . .8 s 其他生物科学 Plant Biology . .9 植物学 Zoology & Entomology 9 动物学与昆虫学 . Business, Economics & Law . .9 商 业 ，经 济 学 与 法 学 Chemistry . .10 化学 Earth & Environmental Sciences . 11 地质学与环境科学 Energy . 11 能源学 Engineering . 12 工程学 Mathematics & Statistics . 13 数学与统计学 Material Sciences . 13 材料科学 Medical & Health Sciences . .14 医学与健康科学 Medicine Multidisciplinary . .14 综合性医学 . 14 Anesthesiology 麻醉学 Cardiorespiratory Medicine/Haematology . .14 心肺医学与血液学 Clinical Neurology . .. .15 临床神经学 Complementary and Integrative Medicine . 15 补充医学 Critical Care & Emergency Medicine . 16 重症监护与急救医学 Dermatology . 16 皮肤病学 Endocrinology & Metabolism . .16 内分泌与代谢 Gastroenterology & Hepatology . 16 胃肠病与肝病学 General/Experimental/Other Medicineand Health Sciences 其他医学与 . 16 健康科学 Geriatrics & Gerontology . 17 老年学 Springer Nature springernature.com 3 开放获取期刊列表 Health Policy & Health Care Services . .17 卫生政策与卫生保健服务 Immunology/Rheumatology/Allergy . 18 风 湿 、免 疫 与 过 敏 学 Infectious Diseases . 18 感染病学 Medical Ethics & Information . 18 医学伦理学与信息学 Nutrition & Dietetics . 19 营养学 Obstetrics & Gynecology . 19 妇产科学 Oncology . 19 肿瘤学 Ophthalmology . 20 眼科学 Orthopedics 骨科学 . ..20 Otorhinolaryngology & Dentistry 耳鼻喉学与口腔医学 . .21 Pathology&Medical Physiology 病理与生理学 .
    [Show full text]
  • Biomed Central Open-Access Research That Covers a Broad Range of Disciplines, and Reaches Influencers and Decision Makers
    The Open Access Publisher 2017 Media Kit BioMed Central Open-access research that covers a broad range of disciplines, and reaches influencers and decision makers. CHEMISTRY SPRINGER NATURE.................2 - BIOCHEMISTRY - GENERAL CHEMISTRY OUR SOLUTIONS.....................3 HEALTH JOURNALS & DISCIPLINES......5 - HEALTH SERVICES RESEARCH - PUBLIC HEALTH BIOLOGY - BIOINFORMATICS - CELL & MOLECULAR BIOLOGY - GENERICS AND GENOMICS - NEUROSCIENCE MEDICINE - CANCER - CARDIOVASCULAR DISORDERS - CRITICAL, INTENSIVE CARE AND EMERGENCY MEDICINE - IMMUNOLOGY - INFECTIOUS DISEASES SPRINGER NATURE SPRINGER NATURE QUALITY CONTENT RESEARCHERS, CLINICIANS, DOCTORS Springer Nature is a leading publisher of scientific, scholarly, professional EARLY-CAREER and educational content. For over a century, our brands have been setting the 20 JOURNALS RANK #1 PROFESSORS, SCIENTISTS, IN 1 OR MORE SUBJECT LIBRARIANS, scientific agenda. We’ve published ground-breaking work on many fundamental STUDENTS CATEGORY* EDUCATORS achievements, including the splitting of the atom, the structure of DNA, and the 9 OF THE TOP 20 SCIENCE JOURNALS BY IMPACT discovery of the hole in the ozone layer, as well as the latest advances in stem- FACTOR* MORE NOBEL LAUREATES cell research and the results of the ENCODE project. BOARD-LEVEL PUBLISHED WITH US THAN ANY POLICY-MAKERS, SENIOR MANAGERS OTHER SCIENTIFIC PUBLISHER OPINION LEADERS Our dominance in the scientific publishing market comes from a company- wide philosophy to uphold the highest level of quality for our readers, authors
    [Show full text]
  • Research Trends Issue 36 March 2014 Research Trends Issue 36 March 2014 Page 01
    Research Trends Issue 36 March 2014 Research Trends Issue 36 March 2014 Page 01 Research Trends Issue 36: Research Assessment & Evaluation The common theme of this issue of In their piece, Andrew Plume and Judith Research Trends is Research Assessment Kamalski discuss how new research and Evaluation. This issue’s contributions methods using download data can be all illustrate that bibliometric or informetric used in national research assessment in indicators are useful tools in the assessment an international context. In another article of research, and in some cases how new on new research methods, Mike Taylor metrics are being explored. and Andrew Plume explore the potentials of “altmetrics”. They show that developing In the opening article Gali Halevi and a good new metric is a complex process I provide an overview of the various that involves the collection of accurate data, quantitative approaches to research definition of a statistically sound metric, assessment that are currently in use, which thorough validation, and a close interaction is followed by a number of contributions with users. that focus on research assessment and evaluation from different angles. Sander Finally, February 28th is Rare Disease Day, van Servellen and Ikuko Oba, for example, an international advocacy day to help raise present a study on a particular research awareness for rare diseases. In honour of field: stem cell research, while Gali Halevi this day, Iris Kisjes used SciVal to examine interviews Dr. Daphne Getz on the way publication trends in the field of rare disease national research evaluation is carried out management. in Israel, by the Samuel Neaman Institute.
    [Show full text]
  • Assessing the Dissemination of COVID-19 Articles Across Social Media with Altmetric and Plumx Metrics: Correlational Study
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2021 Assessing the dissemination of COVID-19 articles across social media with Altmetric and PlumX metrics: Correlational study Haley N Tornberg Carine Moezinia Chapman Wei Simone A Bernstein Chaplin Wei See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Authors Haley N Tornberg, Carine Moezinia, Chapman Wei, Simone A Bernstein, Chaplin Wei, Refka Al-Beyati, Theodore Quan, and David J Diemert JOURNAL OF MEDICAL INTERNET RESEARCH Tornberg et al Original Paper Assessing the Dissemination of COVID-19 Articles Across Social Media With Altmetric and PlumX Metrics: Correlational Study Haley N Tornberg1*, BS; Carine Moezinia1*, MD; Chapman Wei2, BS; Simone A Bernstein3, MD; Chaplin Wei4, BS; Refka Al-Beyati5, MD; Theodore Quan2, BS; David J Diemert2, MD, FRCP 1Department of Medicine, Hospital for Special Surgery, New York, NY, United States 2Department of Medicine, The George Washington School of Medicine and Health Sciences, Washington, DC, United States 3Department of Psychiatry, Washington University School of Medicine and Barnes-Jewish Hospital, St. Louis, MO, United States 4Department of Medicine, American University of Antigua, Coolidge, Antigua and Barbuda 5Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, CA, United States *these authors contributed equally Corresponding Author: Refka Al-Beyati, MD Department of Medicine David Geffen School of Medicine at University of California 10833 Le Conte Ave Los Angeles, CA United States Phone: 1 3133102931 Email: [email protected] Abstract Background: The use of social media assists in the distribution of COVID-19 information to the general public and health professionals.
    [Show full text]
  • Assessing the Dissemination of COVID-19 Articles Across Social Media with Altmetric and Plumx Metrics: Correlational Study
    JOURNAL OF MEDICAL INTERNET RESEARCH Tornberg et al Original Paper Assessing the Dissemination of COVID-19 Articles Across Social Media With Altmetric and PlumX Metrics: Correlational Study Haley N Tornberg1*, BS; Carine Moezinia1*, MD; Chapman Wei2, BS; Simone A Bernstein3, MD; Chaplin Wei4, BS; Refka Al-Beyati5, MD; Theodore Quan2, BS; David J Diemert2, MD, FRCP 1Department of Medicine, Hospital for Special Surgery, New York, NY, United States 2Department of Medicine, The George Washington School of Medicine and Health Sciences, Washington, DC, United States 3Department of Psychiatry, Washington University School of Medicine and Barnes-Jewish Hospital, St. Louis, MO, United States 4Department of Medicine, American University of Antigua, Coolidge, Antigua and Barbuda 5Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, CA, United States *these authors contributed equally Corresponding Author: Refka Al-Beyati, MD Department of Medicine David Geffen School of Medicine at University of California 10833 Le Conte Ave Los Angeles, CA United States Phone: 1 3133102931 Email: [email protected] Abstract Background: The use of social media assists in the distribution of COVID-19 information to the general public and health professionals. Alternative-level metrics (ie, altmetrics) and PlumX metrics are new bibliometrics that can assess how many times a scientific article has been shared and how much a scientific article has spread within social media platforms. Objective: Our objective was to characterize and compare the traditional bibliometrics (ie, citation count and impact factors) and new bibliometrics (ie, Altmetric Attention Score [AAS] and PlumX score) of the top 100 COVID-19 articles with the highest AASs.
    [Show full text]
  • Tracing Scientist's Research Trends Realtimely
    Wang, X. W., Wang, Z., Xu, S. M. (2012). Tracing scientist’s research trends realtimely [J] Scientometrics, DOI: 10.1007/s11192-012-0884-5. Tracing scientist's research trends realtimely Xianwen Wang*1,2, Zhi Wang†1,2, Shenmeng Xu†1,2 1. WISE Lab, Faculty of Humanities and Social Sciences, Dalian University of Technology, Dalian 116085, China 2.School of Public Administration and Law, Dalian University of Technology, Dalian 116085, China * Corresponding author. Email address: [email protected] † These authors contributed equally as second authors. Abstract In this research, we propose a method to trace scientists' research trends realtimely. By monitoring the downloads of scientific articles in the journal of Scientometrics for 744 hours, namely one month, we investigate the download statistics. Then we aggregate the keywords in these downloaded research papers, and analyze the trends of article downloading and keyword downloading. Furthermore, taking both the download of keywords and articles into consideration, we design a method to detect the emerging research trends. We find that in scientometrics field, social media, new indices to quantify scientific productivity (g-index), webometrics, semantic, text mining, open access are emerging fields that scientometrics researchers are focusing on. Keywords Research trend; Altmetrics; Springer; Realtime; Scientometrics; Download Introduction Tracing research trends is one of the subjects which are of particular interest to scientists, because it helps them to grasp the realtime development and future direction of science and technology. As the scientific community grows, academic publications are also increasing explosively, reaching an unprecedented number and involving more academic sectors and disciplines. Preferentially reading articles from specific journals can no longer satisfy the need of scientists to follow up the latest research trends.
    [Show full text]
  • 30-Day Impact Challenge: the Ultimate Guide to Raising the Profile of Your Research by Stacy Konkiel
    The 30-Day Impact Challenge: the ultimate guide to raising the profile of your research By Stacy Konkiel The text and image contents of this eBook are copyright Impactstory.org and licensed for reuse, remixing, and redistribution under a CC-BY 4.0 license (unless otherwise noted). Table of Contents Introduction Day 1: Make a profile on Academia.edu Day 2: Make a ResearchGate profile Day 3: Create a Google Scholar Profile Day 4: Connect with other researchers on Mendeley Day 5: Make LinkedIn work for your research Day 6: Create an academic website Day 7: Establish your expertise with a science blog Day 8: Promote your research with Kudos Day 9: Find your community on Twitter Day 10: Explore using Facebook in a professional context Day 11: Social media automation for academics Day 12: Make your data discoverable on a data repository Day 13: Share your research software on GitHub Day 14: Slideshare for conference talks Day 15: Publish Open Access for more citations Day 16: Post your preprints Day 17: Claim your ORCID identifier Day 18: Make a video abstract for your research Day 19: Establish your expertise with Open Peer Review Day 20: Stay up-to-date on your colleague’s work Day 21: Stay up-to-date on your entire field Day 22: Get your research to the press Day 23: Make connections and promote your work on listservs Day 24: Hustle at conferences Day 25: Mentor other scientists Day 26: Expand your co-authorship base Day 27: Track your scholarly social media and website impacts Day 29: Discover when your work is discussed & shared online Day 30: Create a comprehensive impact profile at Impactstory Introduction In a hugely competitive research landscape, scientists can no longer afford to just publish and hope for the best.
    [Show full text]
  • Making Open Science a Reality”, OECD Science, Technology and Industry Policy Papers, No
    Please cite this paper as: OECD (2015-10-15), “Making Open Science a Reality”, OECD Science, Technology and Industry Policy Papers, No. 25, OECD Publishing, Paris. http://dx.doi.org/10.1787/5jrs2f963zs1-en OECD Science, Technology and Industry Policy Papers No. 25 Making Open Science a Reality OECD Please cite this paper as: OECD (2015), “Making Open Science a Reality”, OECD Science, Technology and Industry Policy Papers, No. 25, OECD Publishing, Paris. http://dx.doi.org/10.1787/5jrs2f963zs1-en OECD Science, Technology and Industry Policy Papers No. 25 Making Open Science a Reality OECD MAKING OPEN SCIENCE A REALITY The statistical data for Israel are supplied by and under the responsibility of the relevant Israeli authorities. The use of such data by the OECD is without prejudice to the status of the Golan Heights, East Jerusalem and Israeli settlements in the West Bank under the terms of international law. This paper is published under the responsibility of the Secretary-General of the OECD. The opinions expressed and the arguments employed herein do not necessarily reflect the official views of OECD member countries. This report was declassified by written procedure by the Committee for Scientific and Technological Policy on 20 August 2015. © OECD/OCDE 2015 Applications for permission to reproduce or translate all or part of this material should be made to: OECD Publications, 2 rue André-Pascal, 75775 Paris, Cedex 16, France; e-mail: [email protected] Photo credit: Cover © Getty Images International. MAKING OPEN SCIENCE A REALITY TABLE
    [Show full text]
  • Biomedcentral (BMC) 2019 – 2020
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Copyright, Fair Use, Scholarly Communication, etc. Libraries at University of Nebraska-Lincoln 6-8-2020 BioMedCentral (BMC) 2019 – 2020 Anqi Shi University of Otawa Heather Morrison University of Ottawa Follow this and additional works at: https://digitalcommons.unl.edu/scholcom Part of the Business Analytics Commons, Intellectual Property Law Commons, Scholarly Communication Commons, and the Scholarly Publishing Commons Shi, Anqi and Morrison, Heather, "BioMedCentral (BMC) 2019 – 2020" (2020). Copyright, Fair Use, Scholarly Communication, etc.. 155. https://digitalcommons.unl.edu/scholcom/155 This Article is brought to you for free and open access by the Libraries at University of Nebraska-Lincoln at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Copyright, Fair Use, Scholarly Communication, etc. by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. Shi and Morrison in Sustaining the Knowledge Commons (June 8, 2020). Also available at https://sustainingknowledgecommons.org/2020/06/08/biomedcentral-2020/. Copyright 2020, the authors. Open access material. BioMedCentral (BMC) 2019 – 2020 by Anqi Shi & Heather Morrison Key points • Open access commercial publishing pioneer BMC is now wholly owned by a private company with a portfolio including lines of business that derive revenue from journal subscriptions, book sales, and textbook sales and rentals • Two former BMC fully OA journals, listed in DOAJ from 2014 – 2018 as having CC-BY licenses, are now hybrid and listed on the Springer website and have disappeared from the BMC website • 67% of BMC journals with APCs in 2019 and 2020 increased in price and 11% decreased in price.
    [Show full text]